Savient Pharmaceuticals, Inc. Announces Appointment of New VP Manufacturing

EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT - News) announced today the appointment of Peter Clarke, Ph.D., to the newly-created position of Vice President, Manufacturing. In this role, he will oversee the company’s manufacturing activities and will report to Philip Yachmetz, Executive Vice President and Chief Business Officer.

MORE ON THIS TOPIC